These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
285 related items for PubMed ID: 14712482
1. Increased expression of c-Ski as a co-repressor in transforming growth factor-beta signaling correlates with progression of esophageal squamous cell carcinoma. Fukuchi M, Nakajima M, Fukai Y, Miyazaki T, Masuda N, Sohda M, Manda R, Tsukada K, Kato H, Kuwano H. Int J Cancer; 2004 Mar 01; 108(6):818-24. PubMed ID: 14712482 [Abstract] [Full Text] [Related]
2. Decreased Smad4 expression in the transforming growth factor-beta signaling pathway during progression of esophageal squamous cell carcinoma. Fukuchi M, Masuda N, Miyazaki T, Nakajima M, Osawa H, Kato H, Kuwano H. Cancer; 2002 Aug 15; 95(4):737-43. PubMed ID: 12209716 [Abstract] [Full Text] [Related]
4. Lack of activated Smad2 in transforming growth factor-beta signaling is an unfavorable prognostic factor in patients with esophageal squamous cell carcinoma. Fukuchi M, Nakajima M, Miyazaki T, Masuda N, Osawa H, Manda R, Tsukada K, Kato H, Kuwano H. J Surg Oncol; 2006 Jul 01; 94(1):51-6. PubMed ID: 16788944 [Abstract] [Full Text] [Related]
5. Ski promotes tumor growth through abrogation of transforming growth factor-beta signaling in pancreatic cancer. Heider TR, Lyman S, Schoonhoven R, Behrns KE. Ann Surg; 2007 Jul 01; 246(1):61-8. PubMed ID: 17592292 [Abstract] [Full Text] [Related]
6. Reduced expression of transforming growth factor-beta receptors is an unfavorable prognostic factor in human esophageal squamous cell carcinoma. Fukai Y, Fukuchi M, Masuda N, Osawa H, Kato H, Nakajima T, Kuwano H. Int J Cancer; 2003 Mar 20; 104(2):161-6. PubMed ID: 12569570 [Abstract] [Full Text] [Related]
9. SnoN overexpression is predictive of poor survival in patients with esophageal squamous cell carcinoma. Akagi I, Miyashita M, Makino H, Nomura T, Hagiwara N, Takahashi K, Cho K, Mishima T, Takizawa T, Tajiri T. Ann Surg Oncol; 2008 Oct 20; 15(10):2965-75. PubMed ID: 18612694 [Abstract] [Full Text] [Related]
10. Efficient TGF-β/SMAD signaling in human melanoma cells associated with high c-SKI/SnoN expression. Javelaud D, van Kempen L, Alexaki VI, Le Scolan E, Luo K, Mauviel A. Mol Cancer; 2011 Jan 06; 10(1):2. PubMed ID: 21211030 [Abstract] [Full Text] [Related]
13. Smad4 and transforming growth factor beta1 expression in patients with squamous cell carcinoma of the esophagus. Natsugoe S, Xiangming C, Matsumoto M, Okumura H, Nakashima S, Sakita H, Ishigami S, Baba M, Takao S, Aikou T. Clin Cancer Res; 2002 Jun 06; 8(6):1838-42. PubMed ID: 12060625 [Abstract] [Full Text] [Related]
16. Differences in Smad4 expression in human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck squamous cell carcinoma. Báez A, Cantor A, Fonseca S, Marcos-Martinez M, Mathews LA, Muro-Cacho CA, Muñoz-Antonia T. Clin Cancer Res; 2005 May 01; 11(9):3191-7. PubMed ID: 15867212 [Abstract] [Full Text] [Related]
17. SnoN co-repressor binds and represses smad7 gene promoter. Briones-Orta MA, Sosa-Garrocho M, Moreno-Alvarez P, Fonseca-Sánchez MA, Macías-Silva M. Biochem Biophys Res Commun; 2006 Mar 17; 341(3):889-94. PubMed ID: 16442497 [Abstract] [Full Text] [Related]
19. FRAT1 overexpression leads to aberrant activation of beta-catenin/TCF pathway in esophageal squamous cell carcinoma. Wang Y, Liu S, Zhu H, Zhang W, Zhang G, Zhou X, Zhou C, Quan L, Bai J, Xue L, Lu N, Xu N. Int J Cancer; 2008 Aug 01; 123(3):561-8. PubMed ID: 18498136 [Abstract] [Full Text] [Related]
20. [Role of Ski/SnoN protein in the regulation of TGF-beta signal pathway]. Lu ZH, Chen J. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr 01; 25(2):233-6. PubMed ID: 12905729 [Abstract] [Full Text] [Related] Page: [Next] [New Search]